| (Values in U.S. Thousands) | May, 2018 | May, 2017 | May, 2016 | May, 2015 | May, 2014 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -5,040 | -4,560 | -9,420 | -11,620 | -11,850 |
| Net Income Growth | -10.53% | +51.59% | +18.93% | +1.94% | -88.69% |
Protalex Inc (PRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Protalex, Inc. is a biopharmaceutical company. It focused on the development of drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis and other forms of arthritis. Protalex, Inc. is based in Summit, New Jersey.
Fiscal Year End Date: 05/31